Brains Bioceutical Corp.: Brains Bioceutical Corp Successfully Obtains Home Office Schedule 1 Controlled Drug License
Brains Bioceutical Corp., One of the rare few EU-GMP Certified CBD API producers in the UK awarded a Schedule 1 Controlled Drug Licence by the UK Home Office, maintaining our industry leading advantage for Cannabinoid based medicines
VANCOUVER, BC / ACCESSWIRE / December 17, 2020 / Brains Bioceutical Corp. ( Brains ) a global leader and manufacturer of pharmaceutical, wellness and veterinary cannabidiol (CBD) Active Pharmaceutical Ingredient (API), is proud to announce its landmark accomplishment of being granted a Schedule 1 Controlled Drug License, which is inclusive of THC, from the United Kingdom Home Office. Concurrently, Brains has begun initial development of its new additional facility for CBD API production and R&D activities associated with other cannabinoids.
Brains Bioceutical Corp Successfully Obtains Home Office Schedule 1 Controlled Drug License albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.